Indian companies are finally learning what doing business is all about. It’s about creating value and then letting go, to release that gain so it can be used for better things.
The sale of Ranbaxy’s drug business to Daiichi Sankyo is a turning point in India’s business landscape. It signals that family-founded firms in India, which are notorious for passing on the baton from generation to generation even though they may be handing over flagging and outmoded businesses, have a chance to think differently.
Malvinder Singh has come of age and opened a window of opportunity that is both modern and necessary. Selling a successful business is somewhat similar to pushing the favourite child out of the house to find its own feet, leaving you to figure what to do with the extra room. The trick now is to be clever at using that little extra like the legendary Li Ka-shing, whose ability to trade his businesses has earned him the distinction of being one of the best asset traders in the world.